Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study

BACKGROUND: Previous studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety and efficacy of low-dose and high-dose once-daily multimatrix mesalamine in ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Croft, Nicholas Michael, Korczowski, Bartosz, Kierkuś, Jarosław, Caballero, Beatriz, Thakur, Manoj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579284/
https://www.ncbi.nlm.nih.gov/pubmed/37855022
http://dx.doi.org/10.1016/j.eclinm.2023.102232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579284/
https://www.ncbi.nlm.nih.gov/pubmed/37855022
http://dx.doi.org/10.1016/j.eclinm.2023.102232

Ejemplares similares